Since 2013 the Global Cannabis Stock Index has represented the overall publicly-traded market for the medical and legal marijuana sector.
The Global Cannabis Stock Index, which is dollar-denominated and based upon the prices of the U.S. listing for each member, is rebalanced quarterly, with each member weighted equally at that time.
For the 12/31/20 rebalancing, each stock was required to have an average daily trading value in excess of $1 million and a minimum price of at least $1.00 (10-day average) as of 12/23/20. Non-U.S. companies must have a U.S. listing in order to be included. The dollar-volume threshold for non-U.S. companies includes both U.S. and non-U.S. volume, but there is an additional requirement that the daily average U.S. dollar-volume be in excess of $100K.
The Global Cannabis Stock Index included 38 companies as of 12/31/20 (announced on 12/24/20 and based on data from 12/23/20): LHSIF, MEDIF and PW were removed, while ACRHF, CLVR, GNLN, HYFM, KERN, PCLOF, SOLCF, TPB AND XXII were added.
Inclusion in the index is not an endorsement or recommendation of any company. The companies included are designed to represent the overall market for the medical and legal marijuana sector. To summarize, it includes both the good and the bad. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. QuoteMedia Data delayed 15 minutes unless otherwise indicated.